It is well known that JAK/STAT3 pathway is considered as one of the most promising new targets for cancer therapy due to its role in tumor cell proliferation, survival, invasion and immunosuppression(Yu et al. 2014; Johnson et al. 2018). The gene discussed is STAT3; the disease is neoplasm.